264 related articles for article (PubMed ID: 24121781)
1. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
[TBL] [Abstract][Full Text] [Related]
4. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
5. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
6. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Milczuk HA
Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
Lee AS; Rosen CA
J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
[TBL] [Abstract][Full Text] [Related]
8. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
Pransky SM; Brewster DF; Magit AE; Kearns DB
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
[TBL] [Abstract][Full Text] [Related]
9. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
10. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
Sheahan P; Sexton S; Russell JD
J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
[TBL] [Abstract][Full Text] [Related]
11. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
12. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
13. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
14. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
15. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
[TBL] [Abstract][Full Text] [Related]
17. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
Hoesli RC; Thatcher AL; Hogikyan ND; Kupfer RA
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):231-236. PubMed ID: 31895450
[TBL] [Abstract][Full Text] [Related]
19. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
20. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]